SCHEMBL6579993

SCHEMBL6579993

O=C(CC1CCCC1)c1c(-c2ccc3cc(O)ccc3c2)oc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
LMNA P02545 2/20 0.54
TP53 P04637 2/20 0.54
HTT P42858 2/20 0.54
CRHBP P24387 1/20 0.54
CRHR2 Q13324 1/20 0.54
L3MBTL1 Q9Y468 4/20 0.43
MAPK1 P28482 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 1/20 0.43
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
RAB9A P51151 1/20 0.40
ANO1 Q5XXA6 7/20 0.39
ATM Q13315 2/20 0.39
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.38
ALDH1A1 P00352 3/20 0.38
HSD17B10 Q99714 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6582364 0.87 CNR2 (0.52) MEN1KMT2ALMNATP53HTT
SCHEMBL6582256 0.85 TP53 (0.49) MEN1KMT2ALMNATP53HTT
SCHEMBL6581758 0.84 LMNA (0.51) MEN1KMT2ALMNATP53HTT
SCHEMBL6580094 0.80 KDM4E (0.49) MEN1KMT2ALMNATP53HTT
SCHEMBL6582211 0.80 ALDH1A1 (0.46) MEN1KMT2AL3MBTL1MAPK1SMN1; SMN2
SCHEMBL6582381 0.79 L3MBTL1 (0.43) MEN1KMT2AL3MBTL1SMN1; SMN2RAB9A
SCHEMBL6581446 0.78 LMNA (0.53) MEN1KMT2ALMNAHTTL3MBTL1
SCHEMBL6582700 0.78 PTPN1 (0.42) MEN1KMT2ALMNATP53HTT
SCHEMBL6581543 0.78 PTPN1 (0.47) MEN1KMT2ALMNATP53HTT
SCHEMBL6583139 0.77 L3MBTL1 (0.56) MEN1KMT2AL3MBTL1CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401822-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) Wyeth (US) 2004-03-31 EP disclosed
US-6599925-B2 Cardiovascular disorders; anticancer agents WYETH 2003-07-29 US disclosed
US-20030018067-A1 Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) WYETH 2003-01-23 US disclosed
WO-2003000671-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) WYETH (US) 2003-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030018067-A1 Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) F2R, SERPINE1, SERPINC1 MEN1 4849/4885KMT2A 4201/4885LMNA 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.